RXDX
Prometheus Biosciences Inc
Price:  
199.92 
USD
Volume:  
1,860,050.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Prometheus EV/EBITDA

-121.8%
Upside

As of 2025-05-31, the EV/EBITDA ratio of Prometheus Biosciences Inc (RXDX) is -58.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Prometheus's latest enterprise value is 9,445.47 mil USD. Prometheus's TTM EBITDA according to its financial statements is -161.61 mil USD. Dividing these 2 quantities gives us the above Prometheus EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.1x - 13.4x 10.8x
Forward P/E multiples 13.1x - 19.8x 16.4x
Fair Price (41.91) - (42.92) (43.60)
Upside -121.0% - -121.5% -121.8%
199.92 USD
Stock Price
(43.60) USD
Fair Price

Prometheus EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA